The association between use of proton pump inhibitors and frailty index among middle-aged and older adults.
Br J Clin Pharmacol
; 2024 Sep 20.
Article
en En
| MEDLINE
| ID: mdl-39305011
ABSTRACT
AIMS:
This study aimed to investigate the association between use of proton pump inhibitors (PPI) and frailty index (FI), and to assess the causality relationship using Mendelian randomization (MR).METHODS:
A total of 9756 middle-aged and older adults from the National Health and Nutrition Examination Survey were included. The FI was evaluated using a previously validated 49-item deficit model to assess frailty status, which is one of the common approaches to measure overall health burden. We performed weighted multivariable-adjusted linear regression to assess the association between PPI use and FI, and conducted a two-sample MR to evaluate causality, employing various sensitivity analyses for robustness. The inverse variance weighted (IVW) method was used as the primary analysis.RESULTS:
Multiple linear regression analysis revealed a positive association between PPI use and FI (ß = 0.048, 95% confidence interval [CI] 0.042-0.054, P < .001). This association was observed in both short-term (≤ 1 year) and long-term (> 1 year) PPI users (P for trend < 0.001). The MR study also revealed a positive association between PPI use and FI based on the IVW method (ß = 1.183, 95% CI 0.474-1.892, P = .001).CONCLUSIONS:
While our findings suggest a potential link between PPI use and FI, they should be interpreted with caution due to the study's limitations. Although the MR analysis suggests a causal relationship, further research, particularly longitudinal studies, is needed to confirm these findings and better establish temporality.
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Revista:
Br J Clin Pharmacol
Año:
2024
Tipo del documento:
Article
País de afiliación:
China